Albert Seymour - 24 Feb 2022 Form 4 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Chief Scientific Officer
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Albert Seymour
Issuer symbol
QTTB
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
4
Filing time
28 Feb 2022, 15:05:20 UTC
Previous filing
12 Jan 2022
Next filing
21 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Employee Stock Option (Right to Buy) Award $0 +128,000 $0.000000 128,000 24 Feb 2022 Common Stock 128,000 $2.71 Direct F1
transaction FIXX Restricted Stock Units Award $0 +21,000 $0.000000 21,000 24 Feb 2022 Common Stock 21,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F3 The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.